Catalyst Wire Dossier Catalyst Wire Dossier

Oral Hexavalent Reassortant Rotavirus Vaccine (Vero Cells)

rotavirus vaccine, live attenuated, hexavalent reassortant · Sinovac Life Sciences Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral Hexavalent Reassortant Rotavirus Vaccine (Vero Cells), covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: The Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) [Phase 1]

See pricing